Your browser doesn't support javascript.
loading
Partial ORF1ab Gene Target Failure with Omicron BA.2.12.1
Kyle G Rodino; David R. Peaper; Brendan J Kelly; Frederic Bushman; Andrew Marques; Hriju Adhikari; Zheng Jin Tu; Rebecca Marrero Rolon; Lars F Westblade; Daniel Green; Gregory J Berry; Fann Wu; Medini K Annavajhala; Anne-Catrin Uhlemann; Bijal A Parikh; Tracy McMillen; Krupa Jani; N. Esther Babady; Anne M Hahn; Robert T Koch; Nathan D Grubaugh; - Yale SARS-CoV-2 Genomic Surveillance Initiative; Daniel D Rhoads.
Affiliation
  • Kyle G Rodino; University of Pennsylvania Perelman School of Medicine
  • David R. Peaper; Yale University
  • Brendan J Kelly; University of Pennsylvania Perelman School of Medicine
  • Frederic Bushman; University of Pennsylvania
  • Andrew Marques; University of Pennsylvania Perelman School of Medicine
  • Hriju Adhikari; University of Pennsylvania Perelman School of Medicine
  • Zheng Jin Tu; Cleveland Clinic
  • Rebecca Marrero Rolon; Weill Cornell Medicine
  • Lars F Westblade; Weill Cornell Medicine
  • Daniel Green; Columbia University Irving Medical Center
  • Gregory J Berry; Columbia University Medical Center
  • Fann Wu; Columbia University Irving Medical Center
  • Medini K Annavajhala; Columbia University Irving Medical Center
  • Anne-Catrin Uhlemann; Columbia University Medical Center
  • Bijal A Parikh; Washington University School of Medicine
  • Tracy McMillen; Memorial Sloan Kettering Cancer Center
  • Krupa Jani; Memorial Sloan Kettering Cancer Center
  • N. Esther Babady; Memorial Sloan Kettering Cancer Center
  • Anne M Hahn; Yale School of Public Health
  • Robert T Koch; Yale School of Public Health
  • Nathan D Grubaugh; Yale School of Public Health
  • - Yale SARS-CoV-2 Genomic Surveillance Initiative;
  • Daniel D Rhoads; Cleveland Clinic
Preprint in English | medRxiv | ID: ppmedrxiv-22274187
ABSTRACT
Mutations in the viral genome of SARS-CoV-2 can impact the performance of molecular diagnostic assays. In some cases, such as S gene target failure, the impact can serve as a unique indicator of a particular SARS-CoV-2 variant and provide a method for rapid detection. Here we describe partial ORF1ab gene target failure (pOGTF) on the cobas(R) SARS-CoV-2 assays, defined by a [≥]2 thermocycles delay in detection of the ORF1ab gene compared to the E gene. We demonstrate that pOGTF is 97% sensitive and 99% specific for SARS-CoV-2 lineage BA.2.12.1, an emerging variant in the United States with spike L452Q and S704L mutations that may impact transmission, infectivity, and/or immune evasion. Increasing rates of pOGTF closely mirrored rates of BA.2.12.1 sequences uploaded to public databases, and, importantly increasing local rates of pOGTF also mirrored increasing overall test positivity. Use of pOGTF as a proxy for BA.2.12.1 provides faster tracking of the variant than whole-genome sequencing and can benefit laboratories without sequencing capabilities.
License
cc_no
Full text: Available Collection: Preprints Database: medRxiv Type of study: Diagnostic study Language: English Year: 2022 Document type: Preprint
Full text: Available Collection: Preprints Database: medRxiv Type of study: Diagnostic study Language: English Year: 2022 Document type: Preprint
...